These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 1318418)

  • 1. Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1992 Jul; 66(7):4556-63. PubMed ID: 1318418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation.
    Ansardi DC; Morrow CD
    J Virol; 1993 Dec; 67(12):7284-97. PubMed ID: 8230452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
    Ansardi DC; Luo M; Morrow CD
    Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.
    Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures.
    Ansardi DC; Porter DC; Morrow CD
    J Virol; 1991 Apr; 65(4):2088-92. PubMed ID: 1848318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
    Bräutigam S; Snezhkov E; Bishop DH
    Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans.
    Porter DC; Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for the P4 amino acid residue in substrate utilization by the poliovirus 3CD proteinase.
    Blair WS; Semler BL
    J Virol; 1991 Nov; 65(11):6111-23. PubMed ID: 1656088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myristoylation is important at multiple stages in poliovirus assembly.
    Moscufo N; Simons J; Chow M
    J Virol; 1991 May; 65(5):2372-80. PubMed ID: 1850017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4.
    Hindiyeh M; Li QH; Basavappa R; Hogle JM; Chow M
    J Virol; 1999 Nov; 73(11):9072-9. PubMed ID: 10516013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag.
    Porter DC; Melsen LR; Compans RW; Morrow CD
    J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cellular cofactor facilitates efficient 3CD cleavage of the poliovirus P1 precursor.
    Blair WS; Li X; Semler BL
    J Virol; 1993 Apr; 67(4):2336-43. PubMed ID: 8383245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles.
    Marc D; Masson G; Girard M; van der Werf S
    J Virol; 1990 Sep; 64(9):4099-107. PubMed ID: 2166807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of poliomyelitis subviral particles in the yeast Saccharomyces cerevisiae.
    Jore JP; Veldhuisen G; Kottenhagen M; Pouwels PH; Foriers A; Rombaut B; Boeyé A
    Yeast; 1994 Jul; 10(7):907-22. PubMed ID: 7985418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myristoylation of the poliovirus polyprotein is required for proteolytic processing of the capsid and for viral infectivity.
    Kräusslich HG; Hölscher C; Reuer Q; Harber J; Wimmer E
    J Virol; 1990 May; 64(5):2433-6. PubMed ID: 2157900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a short, highly conserved, motif required for picornavirus capsid precursor processing at distal sites.
    Kristensen T; Belsham GJ
    PLoS Pathog; 2019 Jan; 15(1):e1007509. PubMed ID: 30657784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poliovirus subviral particles associated with progeny RNA in the replication complex.
    Pfister T; Egger D; Bienz K
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():63-71. PubMed ID: 7844543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase.
    Ansardi DC; Pal-Ghosh R; Porter D; Morrow CD
    J Virol; 1995 Feb; 69(2):1359-66. PubMed ID: 7815522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection.
    Porter DC; Ansardi DC; Choi WS; Morrow CD
    J Virol; 1993 Jul; 67(7):3712-9. PubMed ID: 8389902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.